Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1932 to 1981 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1932\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte growth factor-regulated tyrosine kinase substrate; human growth factor-regulated tyrosine kinase substrate. [source:refseq;acc:nm\_004712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10300\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9701.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 7. [source:swissprot;acc:p83436]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 2 protein (ws beta-transducin repeats protein) (ws-betatrp) (williams-beuren syndrome chromosome region 13 protein). [source:swissprot;acc:q9y4p3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5949.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6313.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06115\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine palmitoyltransferase 1 (ec 2.3.1.50) (long chain base biosynthesis protein 1) (lcb 1) (serine-palmitoyl-coa transferase 1) (spt 1) (spt1). [source:swissprot;acc:o15269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6167.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6544.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams-beuren syndrome critical region protein 20 copy b. [source:refseq;acc:nm\_145645]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5171.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5486.96\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06101\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams beuren syndrome critical region 20a isoform 2; nol1/nop2/sun gene family member; williams-beuren syndrome critical region protein 20 copy a; williams beuren syndrome chromosome region 20. [source:refseq;acc:nm\_018044]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams beuren syndrome chromosome region 20c isoform 1. [source:refseq;acc:nm\_032158]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5669.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6015.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
m-phase inducer phosphatase 3 (ec 3.1.3.48) (dual specificity phosphatase cdc25c). [source:swissprot;acc:p30307]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4450.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4721.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5521.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5856.93\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06083\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage factor i, 59 kda subunit. [source:refseq;acc:nm\_024811]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5805.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6158.16\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p300/cbp-associated factor (ec 2.3.1.-) (p/caf) (histone acetylase pcaf). [source:swissprot;acc:q92831]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7210.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7649.23\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06079\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
general control of amino acid synthesis protein 5-like 2 (ec 2.3.1.-) (histone acetyltransferase gcn5) (hsgcn5). [source:swissprot;acc:q92830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7210.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7648.94\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, non-muscle isoform (18 kda phosphoprotein) (p18). [source:swissprot;acc:p23528]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06074\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, muscle isoform (cofilin 2). [source:swissprot;acc:q9y281]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 100 kda subunit (tafii-100) (tafii100). [source:swissprot;acc:q15542]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7195.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7632.83\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
destrin (actin-depolymerizing factor) (adf). [source:swissprot;acc:p18282]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin fusion degradation protein 1 homolog (ub fusion protein 1). [source:swissprot;acc:q92890]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1950\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1. [source:refseq;acc:nm\_018292]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5888.32\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6245.89\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06073\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uracil-dna glycosylase, mitochondrial precursor (ec 3.2.2.-) (udg). [source:swissprot;acc:p13051]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5195.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5510.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nin one binding protein; adenocarcinoma antigen recognized by t lymphocytes 4. [source:refseq;acc:nm\_014062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4689.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4973.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06048\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 20/15 kda subunits (tafii- 20/tafii-15) (tafii20/tafii15). [source:swissprot;acc:q16514]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7019.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7444.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06044\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5448.35\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5777.35\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06039\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor u2af 65 kda subunit (u2 auxiliary factor 65 kda subunit) (u2 snrnp auxiliary factor large subunit) (hu2af(65)). [source:swissprot;acc:p26368]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6297.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanine-4-hydroxylase (ec 1.14.16.1) (pah) (phe-4- monooxygenase). [source:swissprot;acc:p00439]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pp3111 protein. [source:refseq;acc:nm\_022156]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 18. [source:swissprot;acc:q9p2w9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rd protein. [source:swissprot;acc:p18615]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3678.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3470.55\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
androgen-induced 1; cgi-103 protein; androgen induced protein. [source:refseq;acc:nm\_016108]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase b chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p24539]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
j domain containing protein 1. [source:swissprot;acc:q9ukb3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3678.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3470.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05993\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 complex subunit 4; likely ortholog of mouse cop9 (constitutive photomorphogenic), subunit 4 (arabidopsis); cop9 (constitutive photomorphogenic, arabidopsis, homolog) subunit 4. [source:refseq;acc:nm\_016129]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6988.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7406.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05985\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor arginine/serine-rich 11 (arginine-rich 54 kda nuclear protein) (p54). [source:swissprot;acc:q05519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5939.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6294.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain only 7; zinc-finger domain-containing protein; lomp protein; f-box only protein 20; f-box protein fbx20. [source:refseq;acc:nm\_005358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5782.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6126.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05946\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog a (hhr23a). [source:swissprot;acc:p54725]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [source:refseq;acc:nm\_001701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6176.71\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/